In adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control
- The only approved DPP-4i that does not require dose reduction based on renal function
- Convenience with always one dose once daily.
- Proven HbA1c lowering efficacy
- Demonstrated long-term CV and kidney safety profile
Achieves greater improvements in glycaemic control than either component alone in patients with type II DM .
Dosage
As recommended by the physician
